Flibanserin for postmenopausal women - Are they really that different?

Maturitas

Volumn 82, Issue 4, 2015, Pages 325-327

  Simon, James A ^a   Dhanuka, Ida ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLIBANSERIN;

DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FEMALE; FEMALE SEXUAL DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HEADACHE; HORMONAL THERAPY; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MULTICENTER STUDY (TOPIC); NAUSEA; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL HEALTH; SOMNOLENCE; WOMEN'S HEALTH;

EID: 84947708126     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.09.008     Document Type: Editorial

References (18)

1. J.A. Simon Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield) Maturitas 69 March 10 2011 197 198
2. A. Dobs, Presented at FDA Advisory Board Meeting, December 2004. Available at: http://www.fda.gov/ohrms/dockets/AC/04/transcripts/2004-4082T1.htm. Androgenic effects.
3. W.B. White, D. Grady, L.C. Giudice, S.M. Berry, J. Zborowski, and M.C. Snabes A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder Am. Heart J. 163 January (1) 2012 27 32
4. J.M. Krapf, and J.A. Simon The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women Maturitas 63 July (3) 2009 213 219
5. L. Nachtigall, P. Casson, J. Lucas, V. Schofield, C. Melson, and J.A. Simon Safety and tolerabililty of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen Gynecol. Endocrinol. 27 January (1) 2011 39 48
6. S.R. Davis, and S. Wahlin-Jacobsen Testosterone in women-the clinical significance Lancet Diabetes Endocrinol. September 7 2015 10.1016/S2213-8587(15)00284-3 pii:S2213-8587(15)00284-3, [Epub ahead of print]
7. S.R. Davis, and S.J. Parish Testosterone in women: can the challenges be met? Lancet Diabetes Endocrinol. 3 August (8) 2015 588 590 10.1016/S2213-8587(15)00207-7 Epub 10.06.2015
8. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. 1994 American Psychiatric Press Washington DC
9. J.L. Shifren, B.U. Monz, P.A. Russo, and et al. Sexual problems and distress in United States women Obstet. Gynecol. 112 5 2008 970 978
10. J.A. Simon, S.A. Kingsberg, B. Shumel, and et al. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial Menopause 21 6 2014
11. C.O. Nastri, L.A. Lara, R.A. Ferriani, A.C. Rosa-E-Silva, J.B. Figueiredo, and W.P. Martins Hormone therapy for sexual function in perimenopausal and postmenopausal women Cochrane Database Syst. Rev. 6 June 5 2013 CD009672 10.1002/14651858 pub2
12. A.H. Clayton, L.R. DeRogatis, R.C. Rosen, and et al. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM V revisions: 1. For women with incomplete loss of desire or sexual receptivity J. Sex. Med. 9 2012 2027 2039
13. R. Balon, and A.H. Clayton Female sexual interest/arousal disorder: a diagnosis out of thin air Arch. Sex. Behav. 43 2014 1227 1229
14. C. Günzler, and M.M. Berner Efficacy of psychosocial interventions in men and women with sexual dysfunctions - a systematic review of controlled clinical trials J. Sex. Med. 9 2012 3108 3125
15. R.E. Pyke, and A.H. Clayton Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective J. Sex. Med. 2015 (in press)
16. Addyi™ package insert. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2015/022526lbl.pdf.
17. I. Dhanuka, and J.A. Simon Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women Expert Opin. Pharmacother. 22 September 2015 1 7
18. R.E. Nappi, and L. Cucinella Advances in pharmacotherapy for treating female sexual dysfunction Expert Opin. Pharmacother. 16 April (6) 2015 875 887